2016 Hepatitis Roundup: Recent Research Findings and Potential Clinical Applications for HBV, HCV, and HCC

Published on Author admin@healthmatterscme.com


Program Overview

Asian American communities bear a disproportionate burden of chronic hepatitis B (CHB) and chronic hepatitis C (CHC) infection. Yet most remain undiagnosed and untreated and are therefore at significant risk for progression to advanced liver disease and premature death. To reduce the burden of untreated CHB and CHC in Asian American communities and the serious consequences of hepatocellular carcinoma (HCC), liver failure, and death, it is vital for health care providers (HCPs) to be aware of the elevated risks of CHB and CHC among their patients of Asian descent and to implement recommended antiviral treatment strategies for all diagnosed patients. In addition, according to AASLD guidelines, because patients with either form of viral hepatitis are at great risk of progression to HCC, clinicians must practice regular screening and surveillance for HCC among these patients. This CME/CE-certified activity will provide clinicians practicing in Asian American communities with information on current advances in CHB and CHC antiviral treatment options and their practical clinical applications. It will also provide both strategies for incorporating the most up-to-date clinical research findings on CHB and CHC into their clinical practice and approaches for effectively communicating with patients in their communities about the risks of these diseases, particularly HCC, and the availability of effective treatments.

The primary goal of this CME/CE-certified activity is to improve outcomes of individuals with CHB, CHC, and HCC by increasing the awareness and knowledge of the most current clinical research findings and state-of-the art treatment approaches among HCPs practicing in Asian communities and in other communities also at increased risk for viral hepatitis.

Target Audience

This activity has been designed to meet the educational needs of physicians, physician assistants, nurse practitioners, and registered nurses who care for patients at risk for HBV or HCV infection.

Educational Objectives

Upon completion of this program, participants will be better able to:

  • Utilize screening and testing guidelines to identify HBV-infected and HCV-infected patients and link them to care and treatment
  • Employ current treatment guidelines for CHB and CHC and differentiate among available treatment agents in terms of efficacy, safety, dosing, and side-effect profile
  • Discuss clinical trial data supporting the use of emerging agents and treatment strategies for CHB to achieve maximal suppression of viral replication in all patients, including those with coinfections, those who are pregnant or plan to become pregnant, those undergoing immunosuppressive therapy, and those with cirrhosis or HCC
  • Discuss clinical trial data supporting the use of new and emerging agents and treatment strategies for CHC to achieve sustained virologic response and a clinical cure in all patients, including those with coinfections, those who inject drugs, and those with cirrhosis, HCC, or other hepatopathies
  • Employ current screening and surveillance guidelines in patients at increased risk for HCC and appropriately treat those with HCC

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and the Asian Health Foundation. Global is accredited by the ACCME to provide continuing medical education for physicians.

* This CME/CE activity complies with all requirements of the federal Physician Payment Sunshine Act. If a reportable event is associated with this activity, the accredited provider managing the program will provide the appropriate physician data to the Open Payments database.

Physician Credit Designation

Global Education Group designates this live activity for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Global Education Group is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s COA.

This educational activity for 3.0 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest

Global Education Group (Global) requires instructors, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient-care recommendations.

Americans With Disabilities Act

Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please call 1-646-674-1820 and ask for Michael Leslie or e-mail healthmatterscme@contacthmc.com

For information about the accreditation of this program, please contact Global at 303-395-1782 or inquire@globaleducationgroup.com

There is no fee for this CME/CE-certified activity.


DECEMBER 10, 2016

Crowne Plaza Houston Reliant Park–Medical

8686 Kirby Drive

Houston, TX

Breakfast & Registration: 8:00 am – 9:00 am CST

Meeting: 9:00 am – 12:30 pm CST

Lunch: 12:30 pm – 1:30 pm CST


OCTOBER 22, 2016

The L.A. Hotel Downtown

333 South Figueroa Street

Los Angeles, CA

Breakfast & Registration: 8:00 am – 9:00 am PDT

Meeting: 9:00 am – 12:30 pm PDT

Lunch: 12:30 pm – 1:30 pm PDT



OCTOBER 22, 2016

Affinia Manhattan

371 7th Avenue

(between 30th and 31st Streets)

New York, NY

Breakfast & Registration: 8:00 am – 9:00 am EDT

Meeting: 9:00 am – 12:30 pm EDT

Lunch: 12:30 pm – 1:30 pm EDT



OCTOBER 8, 2016

Sheraton Fisherman’s Wharf

2500 Mason Street

San Francisco, CA

Breakfast & Registration: 8:00 am – 9:00 am PDT

Meeting: 9:00 am – 12:30 pm PDT

Lunch: 12:30 pm – 1:30 pm PDT


Son T. Do, MD
Past Chairman
National Task Force on Hepatitis B:
Focus on Asian and
Pacific Islander Americans
Digestive Health Associates of Texas
Plano, TX

Steven-Huy B.  Han, MD, AGAF, FAASLD
Professor of Medicine and Surgery
Program Director, Transplant Hepatology Fellowship; Director, Hepatology Clinical Research
David Geffen School of Medicine at UCLA
Los Angeles, CA

Thuan Nguyen, MD
Medical Director
Liver and Digestive Consultants
Houston, TX


Professor of Medicine
Director of Hepatology Services
University of California, Irvine
Orange, CA

Myron J. Tong, MD, PhD
Professor of Digestive Diseases/
David Geffen School of Medicine at UCLA
Director of Hepatology
UCLA Asian Liver Center
Associate Director
UCLA Liver Cancer Center
Los Angeles, CA

Tse-Ling Fong, MD
Associate Professor of Medicine
Keck School of Medicine of University of Southern California
Keck Medical Center
Los Angeles, CA



Danny Chu, MD
Clinical Instructor
NYU Langone Medical School
New York, NY

Paul J. Gaglio, MD
Professor of Medicine (in Surgery)
Director, Hepatology Outreach
Center for Liver Disease
and Transplantation–
NewYork-Presbyterian Hospital
Columbia University Medical Center
New York, NY

Albert D. Min, MD
Professor of Medicine
Icahn School of Medicine at Mount Sinai
Director of Hepatology
Division of Digestive Diseases
Mount Sinai Beth Israel
New York, NY



Joseph Ahn, MD, MS
Associate Professor of Medicine
Director of Hepatology
Oregon Health & Science University
Portland, OR

Christopher L. Bowlus, MD
Professor and Chief
Division of Gastroenterology
and Hepatology
UC Davis School of Medicine
Sacramento, CA

Naoky Tsai, MD
Clinical Professor of Medicine
John A. Burns School of Medicine
University of Hawaii
Medical Director
Queens Liver Center and
Liver Transplant Program
Honolulu, HI

Register Now

Contact Information
Phone: 646-674-9547



If you encounter problems registering, please contact us at AHFinfo@contacthmc.com

Online Registration

Bookings are closed for this event.